Strata Critical Medical, Inc.
SRTA
$4.34
$0.040.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 84.29% | -50.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 84.29% | -50.74% | |||
| Cost of Revenue | 80.43% | -50.66% | |||
| Gross Profit | 98.06% | -51.04% | |||
| SG&A Expenses | 76.30% | -64.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 80.49% | -55.35% | |||
| Operating Income | 34.65% | 88.36% | |||
| Income Before Tax | -539.11% | 56.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -532.00% | 56.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1,633.96% | -7.16% | |||
| EBIT | 34.65% | 88.36% | |||
| EBITDA | -117.69% | 115.17% | |||
| EPS Basic | 1,610.41% | -5.49% | |||
| Normalized Basic EPS | 46.67% | 110.91% | |||
| EPS Diluted | 1,604.34% | -5.49% | |||
| Normalized Diluted EPS | 46.67% | 110.91% | |||
| Average Basic Shares Outstanding | 2.29% | 0.90% | |||
| Average Diluted Shares Outstanding | 2.29% | 0.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||